01.06.2003 | Original Article
Phase III study of combined chemohormonal therapy in metastatic prostate cancer (ECOG 3882)
An eastern cooperative oncology group study
Erschienen in: Medical Oncology | Ausgabe 2/2003
Einloggen, um Zugang zu erhalten